PERMIXON

This brand name is authorized in France, Israel, Lithuania, Tunisia

Active ingredients

The drug PERMIXON contains one active pharmaceutical ingredient (API):

1 Serenoa repens extract
UNII 487DXM62F2 - SERENOA REPENS WHOLE
Read about Sabalis serrulatae fructus

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G04CX02 Sabalis serrulatae fructus G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CX Other drugs used in benign prostatic hypertrophy
Discover more medicines within G04CX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: FR Base de données publique des médicaments Identifier(s): 60074432, 60079721, 60200678, 60263461, 60953665, 61679256, 61743292, 62695740, 63398507, 64472177, 65788274, 66515809, 68830999
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4590
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1016065
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 6063022

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.